http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35951083

Outgoing Links

Predicate Object
contentType Journal Article
endingPage e240
issn 0041-1337
issueIdentifier 9
pageRange e238-e240
publicationName Transplantation
startingPage e238
bibliographicCitation Al Jurdi A, Morena L, Verhoeff R, Alzahrani N, Kotton CN, Riella LV. Tixagevimab-cilgavimab Preexposure Prophylaxis in Solid Organ Transplant Recipients Is Associated With Fewer Breakthrough SARS-CoV-2 Infections, Except During the BA.5 Period. Transplantation. 2023 Sep 01;107(9):e238–40. doi: 10.1097/tp.0000000000004697. PMID: 37271875.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb3bf537cc617ff6d71dcbf26f3cae84
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_431e891495e968567576eab385bab564
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_823fe9bc6b2854b9a32020d15056e985
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c4c63af3231690502ec79855f5e3cc5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_502d75f519028760c477e65bb46533bd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93ca46d794018eb495247e130d3f5653
date 2023-08-21^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/37271875
https://doi.org/10.1097/tp.0000000000004697
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7838
https://portal.issn.org/resource/ISSN/0041-1337
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Tixagevimab–cilgavimab Preexposure Prophylaxis in Solid Organ Transplant Recipients Is Associated With Fewer Breakthrough SARS-CoV-2 Infections, Except During the BA.5 Period
discusses http://id.nlm.nih.gov/mesh/M000744508
http://id.nlm.nih.gov/mesh/M000744506
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D016377Q000009
http://id.nlm.nih.gov/mesh/D000086382Q000517
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000086402
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D066027

Showing number of triples: 1 to 30 of 30.